Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Olivia Pocha"'
Autor:
Albert Jang, Sree M. Lanka, Minqi Huang, Crystal V. Casado, Sydney A. Caputo, Patrick L. Sweeney, Kanika Gupta, Olivia Pocha, Nicholas Habibian, Madeline E. Hawkins, Alexandra D. Lieberman, Jennifer Schwartz, Ellen B. Jaeger, Patrick J. Miller, Jodi L. Layton, Pedro C. Barata, Brian E. Lewis, Elisa M. Ledet, Oliver Sartor
Publikováno v:
The Prostate.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2ee84af6badff99fc91ac43838ce6af
https://doi.org/10.1002/pros.24544
https://doi.org/10.1002/pros.24544
Autor:
Crystal Casado, Sydney Caputo, Ellen B. Jaeger, Albert Jang, Patrick L Sweeney, Sree M Lanka, Kanika Gupta, Olivia Pocha, Maddie Hawkins, Minqi Huang, Alexandra Lieberman, Jennifer Schwartz, Patrick Miller, Pedro C. Barata, Jodi Lyn Layton, Brian E. Lewis, Elisa M. Ledet, A. Oliver Sartor
Publikováno v:
Journal of Clinical Oncology. 41:248-248
248 Background: mCRPC patients with liver metastases have a poor prognosis and often progress rapidly on a variety of treatments. Previously, preliminary ctDNA analyses of mCRPC patients with liver metastases showed a range of commonly altered genes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcf0a389a275f6f0ec2f067c888bbe8c
https://doi.org/10.1200/jco.2023.41.6_suppl.248
https://doi.org/10.1200/jco.2023.41.6_suppl.248
Autor:
Kanika Gupta, Sydney Caputo, Crystal Casado, Albert Jang, Patrick L Sweeney, Sree M Lanka, Olivia Pocha, Maddie Hawkins, Alexandra Lieberman, Jennifer Schwartz, Patrick Miller, Ellen B. Jaeger, Pedro C. Barata, Jodi Lyn Layton, Brian E. Lewis, Elisa M. Ledet, A. Oliver Sartor
Publikováno v:
Journal of Clinical Oncology. 41:230-230
230 Background: Somatic alterations change over time in response to treatment and disease progression in patients with prostate cancer (PCa). We report ctDNA findings of patients who died from PCa within 3 months of a ctDNA assessment to better chara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5bdeb9cfd54d9ef194071dc112803e0
https://doi.org/10.1200/jco.2023.41.6_suppl.230
https://doi.org/10.1200/jco.2023.41.6_suppl.230
Autor:
Sree M Lanka, Albert Jang, Patrick L Sweeney, Kanika Gupta, Sydney Caputo, Crystal Casado, Minqi Huang, Olivia Pocha, Maddie Hawkins, Alexandra Lieberman, Jennifer Schwartz, Ellen B. Jaeger, Patrick Miller, Jodi Lyn Layton, Pedro C. Barata, Brian E. Lewis, Elisa M. Ledet, A. Oliver Sartor
Publikováno v:
Journal of Clinical Oncology. 41:243-243
243 Background: Lutetium-177- PSMA-617 (Lu-177) is a radioligand therapy that delivers radiation to PSMA-expressing cells in patients with advanced prostate cancer. In this study, we aimed to analyze ctDNA in responders and non-responders after Lu-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb1f48004c79ffcd8db7293e178857e6
https://doi.org/10.1200/jco.2023.41.6_suppl.243
https://doi.org/10.1200/jco.2023.41.6_suppl.243
Autor:
Albert Jang, Minqi Huang, Crystal Casado, Sydney Caputo, Patrick L Sweeney, Sree M Lanka, Kanika Gupta, Olivia Pocha, Nicholas Habibian, Maddie Hawkins, Alexandra Lieberman, Jennifer Schwartz, Ellen B. Jaeger, Patrick Miller, Jodi Lyn Layton, Pedro C. Barata, Brian E. Lewis, Elisa M. Ledet, A. Oliver Sartor
Publikováno v:
Journal of Clinical Oncology. 41:35-35
35 Background: Genetic differences between African American and Caucasian patients with advanced prostate cancer may contribute to racial disparities in terms of treatment outcomes and survival, hence further exploration is warranted. We assessed ctD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b24d105f155a942db994b9c549f20686
https://doi.org/10.1200/jco.2023.41.6_suppl.35
https://doi.org/10.1200/jco.2023.41.6_suppl.35
Autor:
Charlotte Hawkins, Olivia Pocha, Elisa M. Ledet, Alexandra Lieberman, Jennifer Schwartz, Maddie Hawkins, Priya Bhandari, Pedro C. Barata, Ellen B. Jaeger, Jodi Lyn Layton, Brian E. Lewis, Kendra Marie Harris, A. Oliver Sartor
Publikováno v:
Journal of Clinical Oncology. 41:54-54
54 Background: A primary challenge facing oncologists is the accurate identification of the source of the rising PSA in the recurrent disease setting and the failure of proper staging at the time of initial therapy. PSMA imaging allows for progress i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9bf459ea1ab100ed78052cf512994b0
https://doi.org/10.1200/jco.2023.41.6_suppl.54
https://doi.org/10.1200/jco.2023.41.6_suppl.54
Autor:
Minqi Huang, Ellen B. Jaeger, Sydney Caputo, Crystal Casado, Albert Jang, Patrick L Sweeney, Sree M Lanka, Kanika Gupta, Alexandra Lieberman, Jennifer Schwartz, Olivia Pocha, Maddie Hawkins, Patrick Miller, Jodi Lyn Layton, Brian E. Lewis, Pedro C. Barata, Elisa M. Ledet, A. Oliver Sartor
Publikováno v:
Journal of Clinical Oncology. 41:253-253
253 Background: Approximately 3-5% of advanced prostate cancer patients have pathogenic BRCA2 mutations in germline tests. In this study, we examine the relationship between pathogenic germline BRCA2 mutation and somatic changes in ctDNA. Methods: Ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c70ea1539270679b567462e599f4d3d
https://doi.org/10.1200/jco.2023.41.6_suppl.253
https://doi.org/10.1200/jco.2023.41.6_suppl.253